Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in parkinson’s disease

Frontiers in Human Neuroscience

Volumn 8, Issue OCT, 2014, Pages 1-9

  Vo, Andrew ^a   Hiebert, Nole M ^a   Seergobin, Ken N ^a   Solcz, Stephanie ^b   Partridge, Allison ^a   MacDonald, Penny A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WESTERN UNIVERSITY   (Canada)

Author keywords

Cognitive impairment; Dopamine; Learning; Parkinson s disease; Stimulus response

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PERGOLIDE; ROPINIROLE;

ACCURACY; ADULT; AGED; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; HUMAN; LEARNING DISORDER; MALE; MIDDLE AGED; PARKINSON DISEASE; STIMULUS RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 84933674385     PISSN: None     EISSN: 16625161     Source Type: Journal    
DOI: 10.3389/fnhum.2014.00784     Document Type: Article

References (50)

1. Asanuma, K., Tang, C., Ma, Y., Dhawan, V., Mattis, P., Edwards, C., et al. (2006). Network modulation in the treatment of Parkinson’s disease. Brain 129, 2667–2678. doi: 10.1093/brain/awl162
2. Ashby, F. G., Ennis, J. M., and Spiering, B. J. (2007). A neurobiological theory of automaticity in perceptual categorization. Psychol. Rev. 114, 632–656. doi: 10.1037/0033-295X.114.3.632
3. Atallah, H. E., Lopez-Paniagua, D., Rudy, J. W., and O’reilly, R. C. (2007). Separate neural substrates for skill learning and performance in the ventral and dorsal striatum. Nat. Neurosci. 10, 126–131. doi: 10.1038/nn1817
4. Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., et al. (2009). The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov. Disord. 24, 1641–1649. doi: 10.1002/mds.22643
5. Breitenstein, C., Korsukewitz, C., Floel, A., Kretzschmar, T., Diederich, K., and Knecht, S. (2006). Tonic dopaminergic stimulation impairs associative learning in healthy subjects. Neuropsychopharmacology 31, 2552–2564. doi: 10.1038/sj.npp.1301167
6. Colzato, L. S., Van Wouwe, N. C., Hommel, B., Zmigrod, S., Ridderinkhof, K. R., and Wylie, S. A. (2012). Dopaminergic modulation of the updating of stimulus-response episodes in Parkinson’s disease. Behav. Brain Res. 228, 82–86. doi: 10.1016/j.bbr.2011.11.034
7. Cools, R. (2006). Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson’s disease. Neurosci. Biobehav. Rev. 30, 1–23. doi: 10.1016/j.neubiorev.2005.03.024
8. Cools, R., Barker, R. A., Sahakian, B. J., and Robbins, T. W. (2001). Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cereb. Cortex 11, 1136–1143. doi: 10.1093/cercor/11.12.1136
9. Cools, R., Barker, R. A., Sahakian, B. J., and Robbins, T. W. (2003). L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease. Neuropsychologia 41, 1431–1441. doi: 10.1016/S0028-3932(03)00117-9
10. Cools, R., Clark, L., Owen, A. M., and Robbins, T. W. (2002). Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J. Neurosci. 22, 4563–4567.
11. Cools, R., Lewis, S. J., Clark, L., Barker, R. A., and Robbins, T. W. (2007). L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson’s disease. Neuropsychopharmacology 32, 180–189. doi: 10.1038/sj.npp.1301153
12. Evans, A. H., Katzenschlager, R., Paviour, D., O’sullivan, J. D., Appel, S., Lawrence, A. D., et al. (2004). Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov. Disord 19, 397–405. doi: 10.1002/mds. 20045
13. Feekes, J. A., and Cassell, M. D. (2006). The vascular supply of the functional compartments of the human striatum. Brain 129, 2189–2201. doi: 10.1093/brain/awl158
14. Feigin, A., Fukuda, M., Dhawan, V., Przedborski, S., Jackson-Lewis, V., Mentis, M. J., et al. (2001). Metabolic correlates of levodopa response in Parkinson’s disease. Neurology 57, 2083–2088. doi: 10.1212/WNL.57.11.2083
15. Feigin, A., Ghilardi, M. F., Carbon, M., Edwards, C., Fukuda, M., Dhawan, V., et al. (2003). Effects of levodopa on motor sequence learning in Parkinson’s disease. Neurology 60, 1744–1749. doi: 10.1212/01.WNL.0000072263.03608.42
16. Frank, M. J., Seeberger, L. C., and O’reilly, R. C. (2004). By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306, 1940–1943. doi: 10.1126/science.1102941
17. Ghilardi, M. F., Feigin, A. S., Battaglia, F., Silvestri, G., Mattis, P., Eidelberg, D., et al. (2007). L-Dopa infusion does not improve explicit sequence learning in Parkinson’s disease. Parkinsonism Relat. Disord. 13, 146–151. doi: 10.1016/ j.parkreldis.2006.08.006
18. Gotham, A., Brown, R., and Marsden, C. (1988). “Frontal” cognitive function in patients with Parkinson’s disease “on” and “off” levodopa. Brain 111, 299–321. doi: 10.1093/brain/111.2.299
19. Graef, S., Biele, G., Krugel, L. K., Marzinzik, F., Wahl, M., Wotka, J., et al. (2010). Differential influence of levodopa on reward-based learning in Parkinson’s disease. Front. Hum. Neurosci. 4:169. doi: 10.3389/fnhum.2010.00169
20. Haber, S. N., and Fudge, J. L. (1997). The primate substantia nigra and VTA: integrative circuitry and function. Crit. Rev. Neurobiol. 11, 323–342. doi: 10.1615/CritRevNeurobiol.v11.i4.40
21. Hiebert, N. M., Vo, A., Hampshire, A., Owen, A. M., Seergobin, K. N., and MacDonald, P. A. (2014). Striatum in stimulus-response learning via feedback and in decision making. Neuroimage 101C, 448–457. doi: 10.1016/j.neuroimage. 2014.07.013
22. Hughes, A. J., Daniel, S. E., Kilford, L., and Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181–184. doi: 10.1136/jnnp.55.3.181
23. Jahanshahi, M., Wilkinson, L., Gahir, H., Dharmaindra, A., and Lagnado, D. A. (2010). Medication impairs probabilistic classification learning in Parkinson’s disease. Neuropsychologia 48, 1096–1103. doi: 10.1016/j.neuropsychologia.2009. 12.010
24. Jessup, R. K., and O’doherty, J. P. (2011). Human dorsal striatal activity during choice discriminates reinforcement learning behavior from the gambler’s fallacy. J. Neurosci. 31, 6296–6304. doi: 10.1523/JNEUROSCI.6421-10.2011
25. Kish, S. J., Shannak, K., and Hornykiewicz, O. (1988). Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 318, 876–880. doi: 10.1056/NEJM198804073181402
26. MacDonald, P. A., MacDonald, A. A., Seergobin, K. N., Tamjeedi, R., Ganjavi, H., Provost, J. S., et al. (2011). The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson’s disease: support from functional MRI. Brain 134, 1447–1463. doi: 10.1093/brain/awr075
27. MacDonald, A. A., Monchi, O., Seergobin, K. N., Ganjavi, H., Tamjeedi, R., and MacDonald, P. A. (2013a). Parkinson’s disease duration determines effect of dopaminergic therapy on ventral striatum function. Mov. Disord. 28, 153–160. doi: 10.1002/mds.25152
28. MacDonald, A. A., Seergobin, K. N., Owen, A. M., Tamjeedi, R., Monchi, O., Ganjavi, H., et al. (2013b). Differential effects of Parkinson’s disease and dopamine replacement on memory encoding and retrieval. PLoS ONE 8:e74044. doi: 10.1371/journal.pone.0074044
29. MacDonald, P. A., and Monchi, O. (2011). Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson’s disease: implications for cognitive function. Parkinsons Dis. 2011:572743. doi: 10.4061/2011/572743
30. McDonald, R. J., and White, N. M. (1993). A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum. Behav. Neurosci. 107, 3–22. doi: 10.1037/0735-7044.107.1.3
31. Mehta, M. A., Swainson, R., Ogilvie, A. D., Sahakian, J., and Robbins, T. W. (2001). Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology (Berl.) 159, 10–20. doi: 10.1007/s002130100851
32. Nelson, H. E., and Willison, J. (1991). National Adult Reading Test (NART). Windsor, UK: NFER-Nelson.
33. O’doherty, J. P. (2004). Reward representations and reward-related learning in the human brain: insights from neuroimaging. Curr. Opin. Neurobiol. 14, 769–776. doi: 10.1016/j.conb.2004.10.016
34. Reiss, J. P., Campbell, D. W., Leslie, W. D., Paulus, M. P., Stroman, P. W., Polimeni, J. O., et al. (2005). The role of the striatum in implicit learning: a functional magnetic resonance imaging study. Neuroreport 16, 1291–1295. doi: 10.1097/01.wnr.0000175615.93312.1a
35. Rodriguez, P. F. (2009). Stimulus-outcome learnability differentially activates anterior cingulate and hippocampus at feedback processing. Learn. Mem. 16, 324–331. doi: 10.1101/lm.1191609
36. Schrag, A., Jahanshahi, M., and Quinn, N. (2000). What contributes to quality of life in patients with Parkinson’s disease? J. Neurol. Neurosurg. Psychiatry 69, 308–312. doi: 10.1136/jnnp.69.3.308
37. Seo, M., Beigi, M., Jahanshahi, M., and Averbeck, B. B. (2010). Effects of dopamine medication on sequence learning with stochastic feedback in Parkinson’s disease. Front. Syst. Neurosci. 4:36. doi: 10.3389/fnsys.2010.00036
38. Shiner, T., Seymour, B., Wunderlich, K., Hill, C., Bhatia, K. P., Dayan, P., et al. (2012). Dopamine and performance in a reinforcement learning task: evidence from Parkinson’s disease. Brain 135, 1871–1883. doi: 10.1093/brain/aws083
39. Shohamy, D., Myers, C. E., Geghman, K. D., Sage, J., and Gluck, M. A. (2006). L-dopa impairs learning, but spares generalization, in Parkinson’s disease. Neuropsychologia 44, 774–784. doi: 10.1016/j.neuropsychologia.2005.07.013
40. Shohamy, D., Myers, C. E., Onlaor, S., and Gluck, M. A. (2004). Role of the basal ganglia in category learning: how do patients with Parkinson’s disease learn? Behav. Neurosci. 118, 676–686. doi: 10.1037/0735-7044.118.4.676
41. Smittenaar, P., Chase, H. W., Aarts, E., Nusselein, B., Bloem, B. R., and Cools, R. (2012). Decomposing effects of dopaminergic medication in Parkinson’s disease on probabilistic action selection–learning or performance? Eur. J. Neurosci. 35, 1144–1151. doi: 10.1111/j.1460-9568.2012.08043.x
42. Swainson, R., Rogers, R. D., Sahakian, B. J., Summers, B. A., Polkey, C. E., and Robbins, T. W. (2000). Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 38, 596–612. doi: 10.1016/S0028-3932(99)00103-7
43. Tomer, R., Aharon-Peretz, J., and Tsitrinbaum, Z. (2007). Dopamine asymmetry interacts with medication to affect cognition in Parkinson’s disease. Neuropsychologia 45, 357–367. doi: 10.1016/j.neuropsychologia.2006.06.014
44. Torta, D. M., Castelli, L., Zibetti, M., Lopiano, L., and Geminiani, G. (2009). On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson’s disease: does the therapy-dose matter? Brain Cogn. 71, 84–91. doi: 10.1016/j.bandc.2009.04.003
45. Tremblay, P. L., Bedard, M. A., Langlois, D., Blanchet, P. J., Lemay, M., and Parent, M. (2010). Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson’s disease. Exp. Brain Res. 205, 375–385. doi: 10.1007/s00221-010-2372-6
46. Voorn, P., Vanderschuren, L. J., Groenewegen, H. J., Robbins, T. W., and Pennartz, C. M. (2004). Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 27, 468–474. doi: 10.1016/j.tins.2004.06.006
47. Wickens, J. R., Horvitz, J. C., Costa, R. M., and Killcross, S. (2007). Dopaminergic mechanisms in actions and habits. J. Neurosci. 27, 8181–8183. doi: 10.1523/JNEUROSCI.1671-07.2007
48. World Medical Association. (2013). World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191–2194. doi: 10.1001/jama.2013.281053
49. Wu, T., Wang, L., Chen, Y., Zhao, C., Li, K., and Chan, P. (2009). Changes of functional connectivity of the motor network in the resting state in Parkinson’s disease. Neurosci. Lett. 460, 6–10. doi: 10.1016/j.neulet.2009. 05.046
50. Yin, H. H., and Knowlton, B. J. (2006). The role of the basal ganglia in habit formation. Nat. Rev. Neurosci. 7, 464–476. doi: 10.1038/nrn1919